Skip to main content
Equibles

MetLife Investment Management, LLC

Position in CDXS — Codexis, Inc.

CIK 1529735 Whippany, NJ
Back to CDXS Full portfolio

Position in CDXS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$117,544
+$31,459 QoQ
Shares Held
52,011
+47.4% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 148 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CDXS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. CDXS ranks #229 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in CDXS

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $117,544 52,011
2025-09-30 $86,085 35,281
2025-06-30 $122,851 50,349
2025-03-31 $53,305 19,816
2024-12-31 $220,183 46,160
2024-09-30 $54,180 17,591
2024-06-30 $121,504 39,195
2024-03-31 $121,888 34,925
2023-12-31 $104,843 34,375
2023-09-30 $64,968 34,375
2023-06-30 $96,250 34,375
2023-03-31 $97,981 23,667
2022-12-31 $153,607 32,963
2022-09-30 $199,755 32,963
2022-06-30 $344,792 32,963
2022-03-31 $679,697 32,963
2021-12-31 $662,267 21,179
2021-09-30 $492,623 21,179
2021-06-30 $557,730 24,613
2021-03-31 $563,391 24,613
2020-12-31 $537,301 24,613
2020-09-30 $288,956 24,613
2020-06-30 $280,588 24,613
2020-03-31 $274,681 24,613